113981-44-5 Cefozopran hydrochloride
| Post Date: | Jan 06,2022 |
| Expiry Date: | Jan 06,2023 |
| Detailed Description: |
Cas No. :113981-44-5;125905-00-2
Identification Molecular Structure Molecular Formula C19H17N9O5S2.HCl |
| CAS Registry Number: |
113981-44-5;125905-00-2 |
| Synonyms: | (6R,7R)-7-[[(2E)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-f]pyridazin-4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid chloride;Cefozopran HCl;1-{[(6R,7R)-7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1H-imidazo[1,2-b]pyridazin-4-ium chloride;[6R-[6alpha,7beta(Z)]]-1-[[7-[[(5-Amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1H-imidazo[1,2-b]pyridazinium chloride;SCE-2787.HCl;Firstcin;(6R,7R)-7-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2(Z)-(methoxyimino)acetamido]-3-(imidazo[1,2-b]pyridazinio-1-ylmethyl)-3-cephem-4-carboxylate hydrochloride; |
| Molecular Formula: | C19H18ClN9O5S2 |
| Molecular Weight: | 551.9865 |
| Molecular Structure: | 
|